Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodolfo Hurle

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
Surgical Oncology|June 9, 2009
Pelvic lymphadenectomy during radical cystectomy: a review of the literatureRodolfo Hurle, Richard Naspro
Arab Journal of Urology|October 8, 2020
Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis?Rodolfo Hurle, Carmen Maccagnano
Frontiers in Oncology|January 30, 2023
Editorial: New frontiers in "bladder sparing" treatments for high risk NMIBCRodolfo Hurle, Massimo Lazzeri
European Urology Oncology|June 29, 2026
Reply to Yue Chang's Letter to the Editor re: Contieri R, Paciotti M, Uleri A, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe trial. Eur Urol Oncol 2026;9:404-12Roberto Contieri, Rodolfo Hurle
World Journal of Urology|February 10, 2025
Comment to: "Identifying optimal candidates for active surveillance in low-grade intermediate-risk non-muscle invasive bladder cancer"Rodolfo Hurle, Roberto Contieri, Massimo Lazzeri
European Urology Focus|April 14, 2023
When and How To Perform Active Surveillance for Low-risk Non-muscle-invasive Bladder CancerRoberto Contieri, Massimo Lazzeri, Rodolfo Hurle
Expert Review of Anticancer Therapy|December 21, 2012
The role of narrow-band imaging in the management of non-muscle-invasive bladder cancerAngelo Naselli, Rodolfo Hurle, Paolo Puppo
The Journal of Urology|April 9, 2021
Editorial CommentRodolfo Hurle, Roberto Contieri, Massimo Lazzeri
European Urology|March 21, 2026
Re: Hiroshi Kitamura, Taiji Tsukamoto, Yoshiyuki Kakehi, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.01.008Roberto Contieri, Massimo Lazzeri, Sisto Perdonà, et al.
BJU International|April 25, 2025
The challenges of conducting a surgical trial-reflections on the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trialStephan Brönimann, Altug Tuncel, Rodolfo Hurle, et al.
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
Surgical Oncology|June 9, 2009
Pelvic lymphadenectomy during radical cystectomy: a review of the literatureRodolfo Hurle, Richard Naspro
Arab Journal of Urology|October 8, 2020
Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis?Rodolfo Hurle, Carmen Maccagnano
Frontiers in Oncology|January 30, 2023
Editorial: New frontiers in "bladder sparing" treatments for high risk NMIBCRodolfo Hurle, Massimo Lazzeri
European Urology Oncology|June 29, 2026
Reply to Yue Chang's Letter to the Editor re: Contieri R, Paciotti M, Uleri A, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe trial. Eur Urol Oncol 2026;9:404-12Roberto Contieri, Rodolfo Hurle
World Journal of Urology|February 10, 2025
Comment to: "Identifying optimal candidates for active surveillance in low-grade intermediate-risk non-muscle invasive bladder cancer"Rodolfo Hurle, Roberto Contieri, Massimo Lazzeri
European Urology Focus|April 14, 2023
When and How To Perform Active Surveillance for Low-risk Non-muscle-invasive Bladder CancerRoberto Contieri, Massimo Lazzeri, Rodolfo Hurle
Expert Review of Anticancer Therapy|December 21, 2012
The role of narrow-band imaging in the management of non-muscle-invasive bladder cancerAngelo Naselli, Rodolfo Hurle, Paolo Puppo
The Journal of Urology|April 9, 2021
Editorial CommentRodolfo Hurle, Roberto Contieri, Massimo Lazzeri
European Urology|March 21, 2026
Re: Hiroshi Kitamura, Taiji Tsukamoto, Yoshiyuki Kakehi, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.01.008Roberto Contieri, Massimo Lazzeri, Sisto Perdonà, et al.
BJU International|April 25, 2025
The challenges of conducting a surgical trial-reflections on the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trialStephan Brönimann, Altug Tuncel, Rodolfo Hurle, et al.
Pageof 19